THE TUMOR SUPPRESSOR NDRG2 DISRUPTS THE ONCOGENICITY OF THE CYTOPLASMIC PRMT5 IN ATL LEUKEMIA
Last updated: 28 Dec 2024
10.21608/avmj.2017.170659
NDRG2, PRMT5, PP2A, ATL, Leukemia
OBEID
SHANAB
Biochemistry Dept., Fac. Vet. Med. South Valley University, Egypt
KAZUHIRO
MORISHITA
Tumor and Cellular Biochemistry Dept., Fac. of Medicine, University of Miyazaki, Japan
AHMED
NASSAR
Biochemistry Dept., Fac. of Medicine. Assiut University, Egypt
MOHAMMED
ISMAIL
Animal Internal Med. Dept., Fac. Vet. Med. South Valley University, Egypt
MOHAMMED
SALAH
Biochemistry Dept., Fac. Vet. Med. South Valley University, Egypt
63
153
24315
2017-04-01
2017-03-12
2017-03-28
145
156
1012-5973
2314-5226
https://avmj.journals.ekb.eg/article_170659.html
https://avmj.journals.ekb.eg/service?article_code=170659
17
Journal
Assiut Veterinary Medical Journal
https://avmj.journals.ekb.eg/
THE TUMOR SUPPRESSOR NDRG2 DISRUPTS THE ONCOGENICITY OF THE CYTOPLASMIC PRMT5 IN ATL LEUKEMIA
Details
Type
Article
Created At
23 Jan 2023